Your browser doesn't support javascript.
loading
Liposomal T cell engager and re-director for tumor cell eradication in cancer immunotherapy.
Xie, Fang; Zhang, Luchen; Shi, Sanyuan; Zheng, Anjie; Di, Jiaxing; Jin, Shanshan; Miao, Xuguang; Wu, Fenglan; Chen, Xiaolong; Zhang, Yanhong; Wei, Xiaohui; Xu, Yuhong.
Afiliação
  • Xie F; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Zhang L; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Shi S; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Zheng A; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Di J; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Jin S; R&D department, Hangzhou Highfield Bipharmaceuticals Ltd, Hangzhou, Zhejiang, China.
  • Miao X; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Wu F; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Chen X; R&D department, Hangzhou Highfield Bipharmaceuticals Ltd, Hangzhou, Zhejiang, China.
  • Zhang Y; R&D department, Hangzhou Highfield Bipharmaceuticals Ltd, Hangzhou, Zhejiang, China.
  • Wei X; School of Pharmacy, Shanghai Jiao Tong University, Shanghai, Jiangsu, China.
  • Xu Y; R&D department, Hangzhou Highfield Bipharmaceuticals Ltd, Hangzhou, Zhejiang, China.
MAbs ; 14(1): 2115205, 2022.
Article em En | MEDLINE | ID: mdl-36041060

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Anticorpos de Cadeia Única / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Anticorpos de Cadeia Única / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article